|
(V1297) |
Interleukin-22 as promising novel biomarker in human Pulmonary Hypertension |
| |
|
S. Dinesh, D. Fiedler, L. Baez, D. Kretzschmar, C. Jung, C. Schulze, M. Franz (Jena, Düsseldorf) |
|
|
Diskussion |
|
(V1298) |
Regnase-1 overexpression in lung endothelium decreases the severity of pulmonary hypertension in mice |
| |
|
A. Remes, P. Kasap, N. Schmiedel, S. Hille, A. Matzen, S. Michalewski, H. Laban, M. Hecker, N. Frey, T. Korff, D. Frank, O. J. Müller (Kiel, Heidelberg) |
|
|
Diskussion |
|
(V1299) |
Echocardiographic assessment of pulmonary artery stiffness in pulmonary hypertension due to left heart disease (PH-LHD) |
| |
|
M. Kucherenko, M. Kukucka, P. Sang, N. Hegemann, J. Grune, W. M. Kuebler, C. Knosalla (Berlin) |
|
|
Diskussion |
|
(V1300) |
The pan-Gq inhibitor FR is a strong pulmonary vasorelaxant in health and disease |
| |
|
A. Seidinger, R. Roberts, G. M. König, E. Kostenis, B. K. Fleischmann, D. Wenzel (Bochum, Bonn; Nottingham, UK) |
|
|
Diskussion |
|
(V1301) |
Therapeutic targeting of pulmonary artery stiffness for treatment of pulmonary hypertension in left heart disease by elastic fiber stabilization |
| |
|
M. Kucherenko, P. Sang, J. Yao, T. Gransar, S. Dhital, J. Grune, S. Simmons, L. Michalick, D. Wulsten, O. Shomroni, F. Hennig, R. Yeter, N. Solowjowa, G. Salinas, G. Duda, V. Falk, N. Vyavahare, W. M. Kuebler, C. Knosalla (Berlin, Göttingen; Clemson, US) |
|
|
Diskussion |
|
(V1302) |
Assessment of Load-Independent Ventricular Contractility to Characterise Right Ventricular Systolic Function and the Potential for Functional Recovery after Load-Modifying Therapies |
| |
|
K.-P. Rommel, S. Rosch, K.-P. Kresoja, C. Besler, T. Kister, M. von Roeder, S. Blazek, C. Lücke, K. Fengler, M. Gutberlet, I. Dähnert, F.-T. Riede, M. I. Brener, H. Thiele, D. Burkhoff, P. Lurz (Leipzig; New York, US) |
|
|
Diskussion |